Business Development Competencies to Maximize the Value of Your Pipeline and In-Licensing Programs

LC4 Consulting is a boutique agency fully focusing on supporting early products and programs in early development, including Business Development Programs. We are offering a breath of experience in a wide range of immunotherapies, auto-immune compounds and biologics in the cancer settings, eg. monoclonal antibodies, Andtibody Drug Conjugates (ADC), and cell based cancer vaccines.

 


Increasing the Commercial Viability of your Life Science Programs in Clinical Development


Areas of Expertise

LC4 offers you an independent advice on your strategic issues and opportunities. With our broad expertise in early development decision making we can guide you with a clear vision and tactical insights for your project.

Commercialization Process and Guidance

Guidance on the SOP for commercialization of early compounds and the required deliverables per development stage (Ph1-2-3).

 


Market Analysis of Therapeutic Landscapes

A systematic strategic analysis of the disease landscape provides the foundation for entering a new therapeutic area.

 



Cross-Functional Work Stream

A key list of cross-functional questions drives the cross-functional alignment on defining the optimal value, pricing and reimbursement of the program.

Lifecycle Planning

Development of the cross-functional recommendations for improving the differentiation strategy and increasing the value proposition.

 



LC4 Offers Innovative Concepts to Increase the Commercial Viability of Your Life Science Programs in Development